Single cell map helps predict childhood Crohn's severity and treatment response

Researchers have developed a comprehensive map of childhood Crohn's disease using single-cell RNA sequencing, which could help predict disease severity and treatment response. The study, published in eLife, is considered an important advancement in understanding pediatric Crohn's disease. The research team analyzed diagnostic biopsies from 14 untreated children with Crohn's disease, repeat biopsies from eight of those patients after treatment, and 13 biopsies from a control group of children with noninflammatory gastrointestinal disorders.

By comparing the cellular profiles of the two groups, they identified specific cell signatures that predict disease severity and treatment outcomes. The study found that an increase in proinflammatory immune cells and a decrease in metabolically specialized cells, which line the healthy intestine, are associated with more severe disease.

Anti-TNF therapy, commonly used to treat Crohn's disease, pushes the cellular ecosystem towards a more severe, treatment-resistant state often seen in adult Crohn's disease. The research team also developed a publicly available bioinformatics tool called ARBOL, which helps create trees of cell states and aids in analyzing the data.

The study, led by co-senior authors Leslie Kean and Jose Ordovas-Montanes, highlights the complexity of genetic and environmental factors influencing pediatric Crohn's disease and the importance of understanding changes in cell composition to predict disease severity and treatment response.